Logo image of NBR

NABORS INDUSTRIES LTD (NBR) Stock Fundamental Analysis

NYSE:NBR - New York Stock Exchange, Inc. - BMG6359F1370 - Common Stock - Currency: USD

40.19  +0.39 (+0.98%)

After market: 40.19 0 (0%)

Fundamental Rating

2

Overall NBR gets a fundamental rating of 2 out of 10. We evaluated NBR against 59 industry peers in the Energy Equipment & Services industry. NBR has a bad profitability rating. Also its financial health evaluation is rather negative. NBR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year NBR has reported negative net income.
In the past year NBR had a positive cash flow from operations.
NBR had negative earnings in each of the past 5 years.
NBR had a positive operating cash flow in each of the past 5 years.
NBR Yearly Net Income VS EBIT VS OCF VS FCFNBR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

NBR has a worse Return On Assets (-4.57%) than 75.86% of its industry peers.
NBR's Return On Equity of -152.45% is on the low side compared to the rest of the industry. NBR is outperformed by 94.83% of its industry peers.
NBR has a worse Return On Invested Capital (4.68%) than 63.79% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for NBR is below the industry average of 8.11%.
The 3 year average ROIC (3.54%) for NBR is below the current ROIC(4.68%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -4.57%
ROE -152.45%
ROIC 4.68%
ROA(3y)-4.38%
ROA(5y)-7.78%
ROE(3y)-88.52%
ROE(5y)-87.38%
ROIC(3y)3.54%
ROIC(5y)N/A
NBR Yearly ROA, ROE, ROICNBR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

Looking at the Operating Margin, with a value of 7.94%, NBR is doing worse than 65.52% of the companies in the same industry.
NBR has a better Gross Margin (40.53%) than 82.76% of its industry peers.
NBR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.94%
PM (TTM) N/A
GM 40.53%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.82%
GM growth 5Y2.06%
NBR Yearly Profit, Operating, Gross MarginsNBR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

2

2. Health

2.1 Basic Checks

NBR has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for NBR has been increased compared to 1 year ago.
Compared to 5 years ago, NBR has more shares outstanding
The debt/assets ratio for NBR has been reduced compared to a year ago.
NBR Yearly Shares OutstandingNBR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
NBR Yearly Total Debt VS Total AssetsNBR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

Based on the Altman-Z score of 0.34, we must say that NBR is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of 0.34, NBR is not doing good in the industry: 75.86% of the companies in the same industry are doing better.
NBR has a debt to FCF ratio of 185.39. This is a negative value and a sign of low solvency as NBR would need 185.39 years to pay back of all of its debts.
NBR has a worse Debt to FCF ratio (185.39) than 70.69% of its industry peers.
NBR has a Debt/Equity ratio of 18.56. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of NBR (18.56) is worse than 93.10% of its industry peers.
Industry RankSector Rank
Debt/Equity 18.56
Debt/FCF 185.39
Altman-Z 0.34
ROIC/WACC0.68
WACC6.92%
NBR Yearly LT Debt VS Equity VS FCFNBR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

NBR has a Current Ratio of 1.75. This is a normal value and indicates that NBR is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.75, NBR perfoms like the industry average, outperforming 46.55% of the companies in the same industry.
A Quick Ratio of 1.52 indicates that NBR should not have too much problems paying its short term obligations.
NBR has a Quick ratio (1.52) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.75
Quick Ratio 1.52
NBR Yearly Current Assets VS Current LiabilitesNBR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

3

3. Growth

3.1 Past

NBR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -234.69%.
NBR shows a decrease in Revenue. In the last year, the revenue decreased by -2.52%.
NBR shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.76% yearly.
EPS 1Y (TTM)-234.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.7%
Revenue 1Y (TTM)-2.52%
Revenue growth 3Y13.25%
Revenue growth 5Y-0.76%
Sales Q2Q%0.74%

3.2 Future

Based on estimates for the next years, NBR will show a very strong growth in Earnings Per Share. The EPS will grow by 26.65% on average per year.
NBR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 0.58% yearly.
EPS Next Y77.24%
EPS Next 2Y43.46%
EPS Next 3Y26.65%
EPS Next 5YN/A
Revenue Next Year6.97%
Revenue Next 2Y0%
Revenue Next 3Y0.58%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NBR Yearly Revenue VS EstimatesNBR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2B 4B 6B
NBR Yearly EPS VS EstimatesNBR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 50 -50 -100

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NBR. In the last year negative earnings were reported.
Also next year NBR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NBR Price Earnings VS Forward Price EarningsNBR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20

4.2 Price Multiples

98.28% of the companies in the same industry are more expensive than NBR, based on the Enterprise Value to EBITDA ratio.
60.34% of the companies in the same industry are cheaper than NBR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 31.85
EV/EBITDA 2.92
NBR Per share dataNBR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200 250

4.3 Compensation for Growth

NBR's earnings are expected to grow with 26.65% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.46%
EPS Next 3Y26.65%

0

5. Dividend

5.1 Amount

No dividends for NBR!.
Industry RankSector Rank
Dividend Yield N/A

NABORS INDUSTRIES LTD

NYSE:NBR (2/28/2025, 8:04:13 PM)

After market: 40.19 0 (0%)

40.19

+0.39 (+0.98%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)10-22 2024-10-22/amc
Earnings (Next)04-22 2025-04-22/amc
Inst Owners88.94%
Inst Owner Change5.67%
Ins Owners6.13%
Ins Owner Change7.14%
Market Cap430.43M
Analysts51.76
Price Target78.54 (95.42%)
Short Float %10.11%
Short Ratio3.15
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.01
Dividend Growth(5Y)-73.53%
DP-0.04%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-117%
Min EPS beat(2)-141.35%
Max EPS beat(2)-92.65%
EPS beat(4)0
Avg EPS beat(4)-133.35%
Min EPS beat(4)-169.97%
Max EPS beat(4)-92.65%
EPS beat(8)1
Avg EPS beat(8)-845.08%
EPS beat(12)2
Avg EPS beat(12)-679.02%
EPS beat(16)3
Avg EPS beat(16)-510.79%
Revenue beat(2)0
Avg Revenue beat(2)-1.08%
Min Revenue beat(2)-1.71%
Max Revenue beat(2)-0.45%
Revenue beat(4)1
Avg Revenue beat(4)-0.68%
Min Revenue beat(4)-1.71%
Max Revenue beat(4)1.05%
Revenue beat(8)1
Avg Revenue beat(8)-1.33%
Revenue beat(12)5
Avg Revenue beat(12)-0.46%
Revenue beat(16)8
Avg Revenue beat(16)-0.03%
PT rev (1m)-13.81%
PT rev (3m)-13.48%
EPS NQ rev (1m)-44.86%
EPS NQ rev (3m)-55.89%
EPS NY rev (1m)-55.67%
EPS NY rev (3m)-199.2%
Revenue NQ rev (1m)-10.08%
Revenue NQ rev (3m)-9.56%
Revenue NY rev (1m)3.83%
Revenue NY rev (3m)4.73%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.15
P/FCF 31.85
P/OCF 0.74
P/B 3.19
P/tB 3.19
EV/EBITDA 2.92
EPS(TTM)-17.27
EYN/A
EPS(NY)-3.93
Fwd EYN/A
FCF(TTM)1.26
FCFY3.14%
OCF(TTM)54.29
OCFY135.08%
SpS273.59
BVpS12.6
TBVpS12.6
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.57%
ROE -152.45%
ROCE 5.92%
ROIC 4.68%
ROICexc 5.2%
ROICexgc 5.2%
OM 7.94%
PM (TTM) N/A
GM 40.53%
FCFM 0.46%
ROA(3y)-4.38%
ROA(5y)-7.78%
ROE(3y)-88.52%
ROE(5y)-87.38%
ROIC(3y)3.54%
ROIC(5y)N/A
ROICexc(3y)4.37%
ROICexc(5y)N/A
ROICexgc(3y)4.37%
ROICexgc(5y)N/A
ROCE(3y)4.47%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.82%
GM growth 5Y2.06%
F-Score5
Asset Turnover0.65
Health
Industry RankSector Rank
Debt/Equity 18.56
Debt/FCF 185.39
Debt/EBITDA 2.89
Cap/Depr 89.66%
Cap/Sales 19.38%
Interest Coverage 1.17
Cash Conversion 67.13%
Profit Quality N/A
Current Ratio 1.75
Quick Ratio 1.52
Altman-Z 0.34
F-Score5
WACC6.92%
ROIC/WACC0.68
Cap/Depr(3y)76.54%
Cap/Depr(5y)57.36%
Cap/Sales(3y)17.15%
Cap/Sales(5y)14.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-234.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-53.7%
EPS Next Y77.24%
EPS Next 2Y43.46%
EPS Next 3Y26.65%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.52%
Revenue growth 3Y13.25%
Revenue growth 5Y-0.76%
Sales Q2Q%0.74%
Revenue Next Year6.97%
Revenue Next 2Y0%
Revenue Next 3Y0.58%
Revenue Next 5YN/A
EBIT growth 1Y-13.13%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year293.46%
EBIT Next 3Y58.54%
EBIT Next 5YN/A
FCF growth 1Y-86.07%
FCF growth 3Y-58.66%
FCF growth 5Y-44.51%
OCF growth 1Y-8.85%
OCF growth 3Y10.68%
OCF growth 5Y-3.21%